Lyme Disease
55
11
12
22
Key Insights
Highlights
Success Rate
76% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
12.7%
7 terminated out of 55 trials
75.9%
-10.6% vs benchmark
20%
11 trials in Phase 3/4
23%
5 of 22 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 22 completed trials
Clinical Trials (55)
A Study to Learn About the Safety, Tolerability, and Immunogenicity of a Fifth Dose of 6-Valent OspA-Based Lyme Disease Vaccine
Human Immune Response to Ixodes Scapularis Tick Bites
A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1982 to Prevent Lyme Disease in Healthy Participants (18 to 70 Years of Age)
A Comprehensive Clinical, Microbiological and Immunological Assessment of Patients With Suspected Post Treatment Lyme Disease Syndrome and Selected Control Populations
A Study to Evaluate Safety and Efficacy of TP-05 in Healthy Participants With Tick Exposure
Borrelia B-cell Diagnostics
Searching for Persistence of Infection in Lyme Disease
Evaluation, Treatment, and Follow-up of Patients With Lyme Disease
Rheumatology Patient Registry and Biorepository
Symptomatic Management of Lyme Arthritis
A School-Based Intervention to Reduce Lyme Disease
An Efficacy, Safety, Tolerability, Immunogenicity, and Lot-Consistency Clinical Trial of a 6-Valent OspA-Based Lyme Disease Vaccine (VLA15)
Safety Study of a Vaccine to Help Protect Against Lyme Disease in Healthy Children
A Study to Evaluate the Safety and Immunogenicity of mRNA-1975 and mRNA-1982 Against Lyme Disease in Participants 18 Through 70 Years of Age
Navigating Pregnancy and Parenthood With Lyme Disease
Safety and Effectiveness of the BlinkER System in Participants With Facial Nerve Palsy
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Lyme Disease
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Serological Measurement of Montpellier Professionals' Contacts with Infectious Agents Responsible for Animal-borne Diseases
Pregnancy and Early Neurodevelopmental Outcomes Following In Utero Lyme Disease Exposure